HELP
HELP
NASDAQ · Pharmaceuticals

Cybin Inc

$4.85
+0.00 (+0.00%)
As of Jun 23, 10:23 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +100.4% upside
Low Target $6.32
Average Target $9.72
High Target $10.76
Current Price $4.85
Current
$4.85
Target
$9.72
$6.32 $9.72 avg $10.76
Scenario Analysis
Bear Case
$6.32
30.3%
Low target
Base Case
$9.72
+100.4%
Avg target
Bull Case
$10.76
+121.9%
High target
Risk/Reward
4.0x
Highly favorable
Price in Context
52-Week High
$12.70
-61.8% from high
52-Week Low
$5.30
+-8.5% from low
Target vs 52W High
$9.72
-23.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%